drugset / Trial / NCT00027521

Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic Cancer

NCT00027521

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Electroporation therapy may enhance the ability of chemotherapy drugs to enter tumor cells. Combining chemotherapy with electroporation therapy may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of electroporation therapy and bleomycin in treating patients who have locally advanced pancreatic cancer.

Timeline

Start
2000-12
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Bleomycin Unknown Other